Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 6 of 6 for “"Virus hepatitis C"”.
-
O papel dos agentes microbianos na carcinogênese.
… to humans, among them are: Helicobacter pylori, hepatitis B virus, hepatitis C virus, human papillomavirus. The study aimed to conduct a literature review on the role of microbes in carcinogenesis, and to study the mechanisms used by these pathogens in the cancer process. The papers were selected …
-
Experiences of injecting drugs, alcohol use and hepatitis C in Merseyside: Barriers to hepatitis C support
Hepatitis C is a blood borne virus affecting the liver. In the UK, approximately 214,000 people are infected with the hepatitis C virus. Hepatitis C disproportionally affects marginalised populations and in the UK sharing equipment used to inject drugs is the main risk factor for hepatitis C …
-
The Structural Basis of Flaviviridae Interaction with Antibodies and Receptors
… are a family of enveloped, positive-stranded RNA viruses responsible for a variety of diseases including encephalitis, hemorrhagic fever and hepatocellular carcinoma. The envelope: E) proteins that coat the outer surface of these viruses provide the molecular machinery that drives receptor …
-
Bindung von Hepatitis C Virus-ähnlichen Partikeln an Zielzellen : ein Modell zur funktionellen Untersuchung von antiviralen Antikörpern
… gehört zu den weltweit wichtigsten Erregern der Hepatitis. Die Mehrzahl der HCV-infizierten Patienten erkrankt an einer chronischen Hepatitis, die zur Leberzirrhose und zum HCC fortschreiten kann. Die Bedeutung von Virus-neutralisierenden Antikörpern für die Viruselimination ist durch das Fehlen …
-
Modulation of the immune response by current and novel treatments for hepatitis C virus
Hepatitis C virus (HCV) infection is a major global healthcare problem infecting 180 million people worldwide. Infection persists in 80% of patients and is thought to result from a failure to sustain an immune response to HCV. Current treatment with ribavirn and PEG-IFN? leads to a sustained viral …